Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Parasitic Diseases Therapeutic Market by Type (Peptides Medicine, Insect Repellent, Acaricide, Other), By Application (Commercial, Household) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Parasitic Diseases Therapeutic Market by Type (Peptides Medicine, Insect Repellent, Acaricide, Other), By Application (Commercial, Household) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 259197 4200 Pharma & Healthcare 377 153 Pages 4.9 (43)
                                          

Industry Growth Insights published a new data on “Parasitic Diseases Therapeutic Market”. The research report is titled “Parasitic Diseases Therapeutic Market research by Types (Peptides Medicine, Insect Repellent, Acaricide, Other), By Applications (Commercial, Household), By Players/Companies Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Pfizer, Sanaria”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Parasitic Diseases Therapeutic Market Research Report

By Type

Peptides Medicine, Insect Repellent, Acaricide, Other

By Application

Commercial, Household

By Companies

Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Pfizer, Sanaria

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

153

Number of Tables & Figures

108

Customization Available

Yes, the report can be customized as per your need.


Global Parasitic Diseases Therapeutic Industry Outlook


Global Parasitic Diseases Therapeutic Market Report Segments:

The global Parasitic Diseases Therapeutic market is segmented on the basis of:

Types

Peptides Medicine, Insect Repellent, Acaricide, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Commercial, Household

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bayer
  2. F. Hoffmann-La Roche
  3. GlaxoSmithKline
  4. Pfizer
  5. Sanaria

Global Parasitic Diseases Therapeutic Market Overview


Highlights of The Parasitic Diseases Therapeutic Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Peptides Medicine
    2. Insect Repellent
    3. Acaricide
    4. Other
  1. By Application:

    1. Commercial
    2. Household
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Parasitic Diseases Therapeutic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Parasitic Diseases Therapeutic Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Parasitic diseases are used therapeutically to treat infections caused by parasites. Parasitic diseases can be treated with medications, surgery, or other treatments.

Some of the major companies in the parasitic diseases therapeutic market are Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Pfizer, Sanaria.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Parasitic Diseases Therapeutic Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Parasitic Diseases Therapeutic Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Parasitic Diseases Therapeutic Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Parasitic Diseases Therapeutic Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Parasitic Diseases Therapeutic Market Size & Forecast, 2018-2028       4.5.1 Parasitic Diseases Therapeutic Market Size and Y-o-Y Growth       4.5.2 Parasitic Diseases Therapeutic Market Absolute $ Opportunity

Chapter 5 Global Parasitic Diseases Therapeutic Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Parasitic Diseases Therapeutic Market Size Forecast by Type
      5.2.1 Peptides Medicine
      5.2.2 Insect Repellent
      5.2.3 Acaricide
      5.2.4 Other
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Parasitic Diseases Therapeutic Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Parasitic Diseases Therapeutic Market Size Forecast by Applications
      6.2.1 Commercial
      6.2.2 Household
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Parasitic Diseases Therapeutic Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Parasitic Diseases Therapeutic Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Parasitic Diseases Therapeutic Analysis and Forecast
   9.1 Introduction
   9.2 North America Parasitic Diseases Therapeutic Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Parasitic Diseases Therapeutic Market Size Forecast by Type
      9.6.1 Peptides Medicine
      9.6.2 Insect Repellent
      9.6.3 Acaricide
      9.6.4 Other
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Parasitic Diseases Therapeutic Market Size Forecast by Applications
      9.10.1 Commercial
      9.10.2 Household
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Parasitic Diseases Therapeutic Analysis and Forecast
   10.1 Introduction
   10.2 Europe Parasitic Diseases Therapeutic Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Parasitic Diseases Therapeutic Market Size Forecast by Type
      10.6.1 Peptides Medicine
      10.6.2 Insect Repellent
      10.6.3 Acaricide
      10.6.4 Other
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Parasitic Diseases Therapeutic Market Size Forecast by Applications
      10.10.1 Commercial
      10.10.2 Household
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Parasitic Diseases Therapeutic Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Parasitic Diseases Therapeutic Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Parasitic Diseases Therapeutic Market Size Forecast by Type
      11.6.1 Peptides Medicine
      11.6.2 Insect Repellent
      11.6.3 Acaricide
      11.6.4 Other
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Parasitic Diseases Therapeutic Market Size Forecast by Applications
      11.10.1 Commercial
      11.10.2 Household
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Parasitic Diseases Therapeutic Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Parasitic Diseases Therapeutic Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Parasitic Diseases Therapeutic Market Size Forecast by Type
      12.6.1 Peptides Medicine
      12.6.2 Insect Repellent
      12.6.3 Acaricide
      12.6.4 Other
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Parasitic Diseases Therapeutic Market Size Forecast by Applications
      12.10.1 Commercial
      12.10.2 Household
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Parasitic Diseases Therapeutic Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Parasitic Diseases Therapeutic Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Parasitic Diseases Therapeutic Market Size Forecast by Type
      13.6.1 Peptides Medicine
      13.6.2 Insect Repellent
      13.6.3 Acaricide
      13.6.4 Other
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Parasitic Diseases Therapeutic Market Size Forecast by Applications
      13.10.1 Commercial
      13.10.2 Household
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Parasitic Diseases Therapeutic Market: Competitive Dashboard
   14.2 Global Parasitic Diseases Therapeutic Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Bayer
      14.3.2 F. Hoffmann-La Roche
      14.3.3 GlaxoSmithKline
      14.3.4 Pfizer
      14.3.5 Sanaria

Our Trusted Clients

Contact Us